Rozmova key facts
as of Oct 2026- Developer of a healthcare platform designed to connect clients with certified psychotherapists and counselors.
- Rozmova is valued at approximately $12.0M as of Oct 2026 (last reported valuation).
- It has raised $1.3M; the latest was Seed Round ($910K) in Jul 2025.
- Notable investors include Seeds of Bravery, Purple Ventures (Brno), Angel One (Ukraine), Dmytro Orel, Google Accelerator — 6 tracked in total.
- Status: Privately Held (backing).
Rozmova's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch Rozmova: the Monday email on marks, rounds and moves
Rozmova funding rounds
No funding rounds for Rozmova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Rozmova valuation
Rozmova's last reported valuation was $12 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Rozmova investors
6 investors are on record for Rozmova, including Seeds of Bravery, Purple Ventures (Brno), Angel One (Ukraine) and Dmytro Orel.
About Rozmova
Developer of a healthcare platform designed to connect clients with certified psychotherapists and counselors. The company allows finding the right therapist and verifies therapists' qualifications, education, and experience, enabling patients to improve their mental health and make psychotherapy more accessible.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2021
- Employees
- 31
- Website
- rozmova.me/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.